Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back
Scientific Session

Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
General Topic: Clinical Science

12S101: ACR Guidelines: Interstitial Lung Disease (ILD)

Sunday, November 12, 2023
7:30 AM – 8:30 AM PT
Location: Ballroom 20D
CE: 1

In Person On Demand

    Speaker(s)

  • Elana Bernstein, MD, MSc

    Columbia University
    New York, NY, United States

    Disclosure(s): Boehringer-Ingelheim: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Ongoing)

  • Sindhu Johnson, MD, PhD

    University of Toronto
    Toronto, ON, Canada

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • Dinesh Khanna, MD, MSc

    University of Michigan
    Ann Arbor, MI, United States

    Disclosure(s): AbbVie: DSMB (Ongoing); AstraZeneca: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing); Bristol-Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); CSL Behring: Consultant (Ongoing); Genentech: Consultant (Ongoing); Horizon Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Grant/Research Support (Ongoing); Prometheus: Consultant (Ongoing)

Presentation of the American College of Rheumatology Guidelines for the screening, monitoring, and treatment of systemic autoimmune rheumatic disease (SARD) associated interstitial lung disease (ILD)

Learning Objectives:

  • Describe the development of the guidelines, the scope of diseases, tests, and treatments, and literature review
  • Introduce the screening, monitoring, and treatments guidelines, highlighting differences across diseases
  • Demonstrate the application of the SARD-ILD guidelines using case vignettes

Presentations:

  • 7:30 AM – 7:45 AM PT
    Developing the Systemic Autoimmune Rheumatic Disease-ILD Guidelines

    Speaker: Elana J. Bernstein, MD, MSc – Columbia University

  • 7:45 AM – 8:00 AM PT
    Presentation of the Systemic Autoimmune Rheumatic Disease-Interstitial Lung Disease Screening, Monitoring, and Treatment Guidelines

    Speaker: Sindhu Johnson, MD, PhD – University of Toronto

  • 8:00 AM – 8:15 AM PT
    Using the Systemic Autoimmune Rheumatic Disease-ILD Guidelines

    Speaker: Dinesh Khanna, MD, MSc – University of Michigan

  • 8:15 AM – 8:30 AM PT
    Q&A